Acadia Pharmaceuticals Overview
Acadia Pharmaceuticals Target Price
Where could ACAD trade next? Consensus target price: $34.
Get informed when a big investor buys or sells
+ FollowShare Price
$28.02
Average Target Price
$33.71
20.3% upside
20.3% upside12 analysts in the last 4 months
High: $49 | Low: $14.5
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-08-25 | Deutsche Bank | $38 | 35.6% upside |  |
| 2026-08-25 | Morgan Stanley | $28 |  0.1% downside | |
| 2026-08-17 | UBS | $49 | 74.9% upside | |
| 2026-08-12 | NeedhamAmi Fadia | $41 | 46.3% upside | |
| 2026-08-10 | Morgan Stanley | $27 | 3.6% downside | |
| 2026-08-05 | RBC CapitalBrian Abrahams | $37 | 32% upside | |
| 2026-08-05 | OppenheimerMatthew Hershenhorn | $25 | 10.8% downside | |
| 2026-07-29 | Raymond James | $14.5 | 48.3% downside | |
| 2026-07-21 | BMO Capital | $36 | 28.5% upside | |
| 2026-07-07 | RBC CapitalBrian Abrahams | $36 | 28.5% upside | |
| 2026-06-29 | Deutsche BankDavid Hoang | $37 | 32% upside | |
| 2026-06-29 | Canaccord GenuitySumant Kulkarni | $36 | 28.5% upside | |
| 2026-03-02 | William Blair | $29 | 3.5% upside | |
| 2026-02-23 | Wolfe ResearchRudy Li | $33 | 17.8% upside | |
| 2026-02-23 | Mizuho Securities | $35 | 24.9% upside | |
| 2026-02-03 | RBC Capital | $31 | 10.6% upside | |
| 2026-01-06 | UBSAshwani Verma | $40 | 42.8% upside | |
| 2026-01-05 | Needham | $34 | 21.3% upside | |
| 2025-12-16 | Stifel Nicolaus | $37 | 32% upside | |
| 2025-12-16 | Piper Sandler | $37 | 32% upside | |
| 2025-12-15 | H.C. Wainwright | $37 | 32% upside | |
| 2025-12-11 | Stifel NicolausPaul Matteis | $25 | 10.8% downside | |
| 2025-12-04 | UBSAshwani Verma | $35 | 24.9% upside | |
| 2025-12-02 | Mizuho Securities | $29 | 3.5% upside | |
| 2025-09-25 | Deutsche Bank | $29 | 3.5% upside | |
| 2025-09-09 | UBS | $39 | 39.2% upside | |
| 2025-08-08 | UBSAshwani Verma | $36 | 28.5% upside | |
| 2025-06-26 | OppenheimerMatthew Hershenhorn | $22 | 21.5% downside | |
| 2025-05-20 | Morgan StanleySean Laaman | $24 | 14.3% downside | |
| 2025-05-19 | NeedhamAmi Fadia | $30 | 7.1% upside | |
| 2025-05-19 | H.C. WainwrightAndrew Fein | $32 | 14.2% upside | |
| 2025-04-28 | UBS | $22 | 21.5% downside | |
| 2025-01-03 | GuggenheimYatin Suneja | $20 | 28.6% downside | |
| 2024-08-07 | Morgan StanleyJeffrey Hung | $20 | 28.6% downside | |
| 2024-06-26 | BMO CapitalKeith Tapper | $31 | 10.6% upside | |
| 2024-05-09 | H.C. WainwrightAndrew Fein | $27 | 3.6% downside | |
| 2024-05-09 | Robert W. BairdJoel Beatty | $28 | 0.1% downside | |
| 2024-05-09 | Mizuho SecuritiesUy Ear | $21 | 25.1% downside | |
| 2024-04-30 | UBSAshwani Verma | $27 | 3.6% downside | |
| 2024-03-12 | UBSAshwani Verma | $33 | 17.8% upside | |
| 2024-03-12 | OppenheimerJay Olson | $19 | 32.2% downside | |
| 2024-03-12 | NeedhamAmi Fadia | $32 | 14.2% upside | |
| 2024-03-12 | Canaccord GenuitySumant Kulkami | $33 | 17.8% upside | |
| 2024-03-12 | JMP SecuritiesJason Butler | $39 | 39.2% upside | |
| 2024-01-24 | NeedhamAmi Fadia | $37 | 32% upside | |
| 2022-11-14 | J.P. Morgan | $17 | 39.3% downside | |
| 2022-08-09 | Morgan Stanley | $18 | 35.8% downside | |
| 2022-08-09 | Mizuho Securities | $19 | 32.2% downside | |
| 2022-08-09 | Goldman Sachs | $15 | 46.5% downside | |
| 2022-08-09 | RBC Capital | $21 | 25.1% downside | |